Morgan Stanley analyst Erin Wright lowered the firm’s price target on Molina Healthcare (MOH) to $158 from $204 and keeps an Equal Weight rating on the shares after lowering the firm’s FY25 and FY26 EPS estimates following the company’s Q3 miss and third guidance cut since July.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Molina Healthcare price target lowered to $170 from $180 at UBS
- Molina Healthcare price target lowered to $180 from $210 at Cantor Fitzgerald
- Molina Healthcare price target lowered to $167 from $207 at Goldman Sachs
- Molina Healthcare price target lowered to $165 from $203 at Deutsche Bank
- Molina Healthcare downgraded to Underweight from Equal Weight at Barclays
